首页> 外文期刊>Kidney international. >3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysis
【24h】

3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysis

机译:3,4-Dideoxyglucosone-3-ene(3,4-DGE):腹膜透析液中的细胞毒性葡萄糖降解产物

获取原文
       

摘要

3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysis.BackgroundBioincompatible glucose degradation products (GDPs) in fluids for peritoneal dialysis (PD) develop during sterilization and storage. Their biological activity has successfully been monitored through the use of various in vitro methods but their molecular and chemical nature is less well understood. Many GDPs are highly reactive carbonyl compounds. Although some of the identified GDPs are extremely cytotoxic, none of them actually possess cytotoxicity at the concentrations found in PD fluids. Thus, the GDP responsible for the toxicity in PD fluids has not yet been identified. The intention of the present work was to investigate to what extent the unsaturated dicarbonyl compound, 3,4-dideoxyglucosone-3-ene (3,4-DGE) was present in PD fluids, and if it could be responsible for the in vitro effects on L-929 fibroblast cells.
机译:3,4-Dideoxyglucosone-3-ene(3,4-DGE):腹膜透析液中的细胞毒性葡萄糖降解产物背景腹膜透析(PD)液中的生物不相容葡萄糖降解产物(GDPs)在灭菌和储存过程中发展。通过使用各种体外方法已成功地监测了它们的生物学活性,但对其分子和化学性质的了解却很少。许多GDP是高反应性的羰基化合物。尽管确定的某些GDP具有极强的细胞毒性,但在PD液体中发现的浓度下,它们实际上都没有细胞毒性。因此,尚未确定造成PD液体毒性的GDP。本研究的目的是研究PD液体中不饱和二羰基化合物3,4-dideoxyglucosone-3-ene(3,4-DGE)的存在程度,以及它是否对体外产生影响在L-929成纤维细胞上

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号